Redwood Investments, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Redwood Investments, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,547,134
-19.6%
328,459
-24.1%
1.70%
-11.0%
Q2 2023$15,614,018
-4.6%
432,881
+1.0%
1.91%
-8.8%
Q1 2023$16,367,088
-34.9%
428,570
-3.0%
2.09%
-37.9%
Q4 2022$25,138,932
+42.5%
441,809
-1.0%
3.37%
+42.0%
Q3 2022$17,637,000
-26.8%
446,049
-18.5%
2.37%
-11.4%
Q2 2022$24,085,000
+65.6%
547,381
+50.1%
2.68%
+94.3%
Q1 2022$14,545,000
-1.4%
364,718
-0.6%
1.38%
+18.3%
Q4 2021$14,753,000
-41.5%
366,897
-40.8%
1.16%
-44.7%
Q3 2021$25,212,000
+3.1%
619,766
+15.1%
2.11%
+6.8%
Q2 2021$24,460,000
+8.1%
538,656
-0.8%
1.97%
-0.8%
Q1 2021$22,628,000
-16.1%
542,764
-14.1%
1.99%
-13.5%
Q4 2020$26,984,000
+71.9%
631,807
+5.7%
2.30%
+73.4%
Q3 2020$15,702,000
+31.3%
597,477
+33.9%
1.32%
+25.3%
Q2 2020$11,959,000446,0701.06%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders